Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997.
By Daniel R. Feikin, A. Schuchat, M. Kolczak, N. Barrett, L. Harrison, L. Lefkowitz, A. McGeer, M. Farley, D. Vugia, C. Lexau and 3 more. American Journal of Public Health, 2000
617 citations recorded by the source corpus.
Subfields: Critical Care and Intensive Care Medicine, Epidemiology, Pharmacology
View Paper: https://www.semanticscholar.org/paper/6f7af9f26d930ad26304fb5f5731033725bd7407
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Critical Care and Intensive Care Medicine
Citations in the corpus
- British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011 (2011, background): “145 [II]146[II] To date, no association with resistance and treatment failure has been demonstrated in children.”
- Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults (2003, background): “The new breakpoints acknowledge that nonmeningeal infections caused by strains formerly considered to be intermediately susceptible and even some that were regarded as resistant can be treated successfully with the usual doses of b-lactam drugs [21] [22] [23] [24] [25] [26] .”
- Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults (2000, neutral): “A CDC study found mortality associated with treated pneumococcal pneumonia to be increased 3-fold when the condition was due to penicillin-resistant pneumococci and 7-fold when due to ceftriaxone-resistant pneumococci, even after adjusting for severity of underlying illness and previous hospitalizat”
- Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults (2007, background): “The available data suggest that the clinically relevant level of penicillin resistance is a MIC of at least 4 mg/L [3].”
- Active bacterial core surveillance of the emerging infections program network. (2001, methodology): “pneumoniae was demonstrated by using multistate clinical and epidemiologic data from ABCs (33).”